Clinical trials for Raynaud's phenomenon

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Raynaud's phenomenon. For all clinical trials, go to clinical trials search

This list shows clinical trials for Raynaud's phenomenon

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Raynaud's phenomenon
Title Recruitment status Location
A study of ORM-12741 for the prevention of blood vessel spasm brought on by cold temperature. Not Recruiting United Kingdom
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon Not recruiting United Kingdom
A study to assess efficacy and safety of selexipag in subjects with Raynaud's Phenomenon secondary to Systemic Sclerosis Not Recruiting United Kingdom
A study to assess efficacy and safety of selexipag in subjects with Raynaud's Phenomenon secondary to Systemic Sclerosis Not Recruiting United Kingdom
Phase III “In-Life” Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud’s Phenomenon - 06-004 A2 Not Recruiting United Kingdom
Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis Not recruiting United Kingdom
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon Not recruiting United Kingdom
Phase III “In-Life” Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud’s Phenomenon - 06-004 A2 Authorised United Kingdom
Topical Amlodipine in Raynaud's Phenomenon Authorised United Kingdom
A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. - Asasantin retard therapy in the management of Raynaud's phenomenon Authorised United Kingdom

Page last reviewed: 03/03/2015

Next review due: 01/03/2018